12:00 AM
 | 
Aug 24, 2015
 |  BC Week In Review  |  Company News  |  Deals

Faulk Pharmaceuticals, Panther Biotechnology deal

Panther completed the acquisition of Faulk’s pharmaceutical assets for 50,000 Panther shares. The shares are valued at $299,500 based on Panther’s close of $5.99 on July...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >